Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients

A clinical trial currently underway at the Comprehensive Cancer Center at UC Davis is investigating the potential of fermented wheat germ to enhance the effectiveness of immunotherapy in cancer patients. This research could lead to significant improvements in patient outcomes, including the possibility of living fuller lives or even overcoming cancer. The study represents a promising avenue in the search for complementary treatments that can boost the body's response to immunotherapy, a cutting-edge approach to cancer treatment that harnesses the patient's own immune system to fight the disease.

Parallel research efforts, such as those by Calidi Biotherapeutics Inc. (NYSE American: CLDI), are also exploring innovative ways to augment cancer treatment protocols. The focus on natural substances like fermented wheat germ underscores the growing interest in integrating traditional and alternative medicine with conventional cancer therapies to achieve better results. For more information on the latest developments in biotechnology and biomedical sciences, visit https://www.BioMedWire.com.